Identifying Cellular Stress-Related mRNA Changes Induced by Novel Xanthone Derivatives in Ovarian Cancer Cells In...

Area of Science:

• Oncology
• Medicinal Chemistry

Background:

• Ovarian cancer presents a significant challenge in oncology with high mortality rates, particularly in advanced stages.
• Current treatments like chemotherapy and surgery have limitations, necessitating the development of novel therapeutic strategies.
• This research explores novel xanthone derivatives incorporating a morpholine ring to enhance anticancer efficacy.

Purpose of the Study:

• To evaluate the potential of novel xanthone derivatives as therapeutic agents for ovarian cancer.
• To assess the in silico toxicity and ADME properties of these compounds.
• To investigate the impact of these derivatives on cellular stress-related genes in ovarian cancer cell lines.

Main Methods:

• In silico analysis using ProTox III and SwissADME for toxicity and ADME profiling.
• Quantitative PCR (qPCR) to analyze gene expression changes in ovarian cancer cell lines (TOV-21G, SKOV-3).
• Treatment of cell lines with synthesized xanthone derivatives to observe molecular responses.

Main Results:

• In silico studies predicted favorable gastrointestinal absorption and blood-brain barrier permeability for the derivatives.
• Compounds displayed varied toxicity and metabolic profiles.
• qPCR analysis indicated significant modulation of genes involved in antioxidant defense, molecular chaperoning, and xenobiotic metabolism.

Conclusions:

• Novel xanthone derivatives exhibit potential as candidates for ovarian cancer therapy.
• These compounds may offer enhanced therapeutic efficacy and strategies to overcome drug resistance.
• Further investigation is required to fully understand the mechanisms of action and optimize treatment strategies.